Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-02-27

FDA Approved: PHENYTOIN INFATABS — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

The FDA approved a supplemental application for PHENYTOIN INFATABS (phenytoin) from Prasco Laboratories under ANDA 084427.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PHENYTOIN INFATABS (Phenytoin)

Snippet

SUPPL AP for PHENYTOIN INFATABS (PHENYTOIN)